Comments: MN HF284 | 2019-2020 | 91st Legislature

Bill Title: Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

Spectrum: Partisan Bill (Democrat 15-0)

Status: (Introduced) 2019-04-01 - Author added Bierman [HF284 Detail]

Text: Latest bill text (Engrossed) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2019 Minnesota HF284 at this time.

Social Comments on MN HF284

feedback